Firstly, I stress I that I am not the expert here on hvads. I think syringe is probably the only one here with the right authoritative knowledge. But based on what little I know, I can quite agree the trading patterns in the short/medium term for HTW could be very similar to VCR. However, longer term, I can see that is where HTW will differ from VCR.
I personally hope that VCR pump will succeed for it will pave the way for a successful HTW pump, it being smaller and all that. As if that is not enough, HTW has an MVAD on the pipeline which is one tenth the size of its HVAD. But what has VCR got in the pipeline? The way I see it, HTW will be the ultimate winner here.
I stress again, I am no heart pump expert. Just giving my opinion based on what announcements I can gather. I used to hold VCR as well but has decided to take up positions in HTW instead based on what little I know and what I can learn from syringe.
Cheers.
VCR
ventracor limited
htw has overtaken vcr finally, page-5
Add to My Watchlist
What is My Watchlist?